Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- RefSeek
- Hamdard University
- EBSCO A-Z
- SWB online catalog
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Advances in Pharmacoepidemiology and Drug Safety have been cited by esteemed scholars and scientists all around the world. Advances in Pharmacoepidemiology and Drug Safety has got h-index 11, which means every article in Advances in Pharmacoepidemiology and Drug Safety has got 11 average citations.
Following are the list of articles that have cited the articles published in Advances in Pharmacoepidemiology and Drug Safety.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
20 | 56 | 30 | 32 | 23 | 3 | 4 | 7 | 22 | 38 | 32 | 27 | 49 |
Research, Review articles and Editorials |
0 | 1 | 1 | 21 | 15 | 3 | 3 | 3 | 14 | 20 | 24 | 17 | 28 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 55 | 31 | 11 | 8 | 0 | 1 | 4 | 8 | 18 | 8 | 10 | 21 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 31 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
43 | 62 | 72 | 97 | 66 | 85 | 68 | 49 | 101 | 34 | 21 | 13 | 0 |
| Journal total citations count | 553 |
| Journal impact factor | 2.86 |
| Journal 5 years impact factor | 4.33 |
| Journal cite score | 5.34 |
| Journal h-index | 11 |
Important citations
Keck T, Strobl A, Weinhaeusel A, Funk P, Michaelis M. Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections–A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial. Frontiers in pharmacology. 2021 Apr 30;12:981.
Yoo KJ, Keshavarzi F. Barriers and Enhancers of Medication Error Reporting Among Hospital Pharmacists, a Qualitative Exploration.
Zafar R, Raza ML. Assessment of look-alike, sound-alike and read-alike (Lasara) medicine–Errors in pharmacy. Journal of the College of Physicians and Surgeons--pakistan: JCPSP. 2020 Apr 1;30(4):425-8.
Keck T, Strobl A, Weinhaeusel A, Funk P, Michaelis M. Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections–A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial. Front. Pharmacol. 12: 666546. doi: 10.3389/fphar. 2021.666546. Frontiers in Pharmacology| www. frontiersin. org. 2021 Apr 30;12.
Mamat R, Awang SA. Development and psychometric validation of a questionnaire to evaluate knowledge and attitude towards medication error reporting among pharmacists. Drug, Healthcare and Patient Safety. 2020;12:95.
Seifert G, Funk P, Reineke T, Lehmacher W. Influence of EPs 7630 on Antipyretic Comedication and Recovery from Acute Tonsillopharyngitis in Children: A Meta-analysis of Randomized, Placebo-Controlled, Clinical Trials. Journal of Pediatric Infectious Diseases. 2021 May;16(03):122-8.
Seifert G, Funk P, Reineke T, Lehmacher W. Influence of EPs 7630 on Antipyretic Comedication and Recovery from Acute Tonsillopharyngitis in Children: A Meta-analysis of Randomized, Placebo-Controlled, Clinical Trials. Journal of Pediatric Infectious Diseases. 2021 May;16(03):122-8.
Riley DS, Lizogub VG, Heger M, Funk P, Mueller H, Lehmacher W. Treatment with EPs 7630, a Pelargonium sidoides root extract, is effective and safe in patients with the common cold: results from a randomized, double blind, placebo-controlled clinical trial. Integrative Medicine: A Clinician's Journal. 2019 Feb;18(1):42.
Ting LC, Moorthy K, Kee HW, Yee CW, Yee LW, Ni OA, Ting W. Service quality and outpatients satisfaction in public hospitals in Malaysia. International Journal of Public Policy and Administration Research. 2019;6(1):57-73.
Matthys H, Funk P. Pelargonium sidoides preparation EPs 7630 in COPD: health-related quality-of-life and other patient-reported outcomes in adults receiving add-on therapy. Current medical research and opinion. 2018 Jul 3;34(7):1245-51.
Seifert G, Brandes-Schramm J, Zimmermann A, Lehmacher W, Kamin W. Faster recovery and reduced paracetamol use–a meta-analysis of EPs 7630 in children with acute respiratory tract infections. BMC pediatrics. 2019 Dec;19(1):1-1.
Kamin W, Funk P, Seifert G, Zimmermann A, Lehmacher W. EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited. Current medical research and opinion. 2018 Mar 4;34(3):475-85.
Schapowal A, Dobos G, Cramer H, Ong KC, Adler M, Zimmermann A, Brandes-Schramm J, Lehmacher W. Treatment of signs and symptoms of the common cold using EPs 7630-results of a meta-analysis. Heliyon. 2019 Nov 1;5(11):e02904.
Careddu D, Pettenazzo A. Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children. International journal of general medicine. 2018;11:91.
Hernández M, Tribiño G, Bustamante C. Caracterización de las potenciales interacciones farmacológicas en pacientes de una unidad de cuidados intensivos en un hospital de tercer nivel de Bogotá. Biomédica. 2018;38(3):407-16.
Hernández Londoño M. Caracterización de las potenciales interacciones fármaco-fármaco en pacientes hospitalizados en una unidad de cuidados intensivos de un hospital de tercer nivel (Bachelor's thesis, Universidad de La Sabana).
Hosseini E, Shojaei L, Karimpour H, Shahbazi F. Potential Drug-Drug Interactions in Critically Ill Medical Patients: A Cross-Sectional Study. Journal of Pharmaceutical Care. 2018:52-7.
Khan T, Muhammad K, Subhan F, Khan Z, Rehman NU. Frequency and nature of potential drug–drug interaction in medical wards: a cross-sectional study in a teaching hospital. Drugs & Therapy Perspectives. 2020 Apr;36(4):158-65.
Qassim S, Metwali Z, Al Hariri Y. WHY THERE IS A NEED FOR DRUG POST MARKETING SURVEILLANCE?.
BG P, Mishra O. Concept, Manufacturing and Characterization of Effervescent Tablets: A Review.